Our Common Stock is listed on the New York Stock Exchange. It is also listed on the London, NYSE Euronext and Swiss stock exchanges, and traded on various United States regional stock exchanges.Stock Transfer Agent and Registrar
Computershare Trust Company, N.A.
250 Royall Street
Canton, MA 02021
Outside the U.S., Canada and
Puerto Rico: 1-781-575-4591
Please contact our Stock Transfer Agent and Registrar with inquiries concerning shareholder accounts of record and stock transfer matters, and also for information on the following services and programs:
- Shareholder Investment Program
- direct purchase of Pfizer stock
- dividend reinvestment
- automatic monthly investments
- Book-entry share ownership
- Direct deposit of dividends
Please refer to Pfizer's 2009 Form 10-K for a description of the substantial risks and uncertainties related to the forward-looking statements included in this Annual Review. Our Form 10-K is available on our Web site at www.pfizer.com/sec and on the Securities and Exchange Commission's Web site at www.sec.gov.Corporate Responsibility Report
This report provides additional detailed information about how Pfizer conducts business responsibly and engages with stakeholders to advance good health and expand a sustainable business. This report is available online at www.pfizer.com/crreport.Political Action Committee (PAC)
To review our most recent PAC and corporate political contributions report, go online at www.pfizer.com/pac.
Our global EHS initiatives, Environmental Sustainability Program and performance metrics may be found online at www.pfizer.com/ehs and in our Corporate Responsibility Report at www.pfizer.com/crreport.Helplines
Patients, customers and health care professionals who have questions about any of our products should call 1-800-438-1985.
Uninsured or underinsured patients who need help getting their Pfizer medicines should call Pfizer Helpful Answers®, our family of patient assistance programs that provide Pfizer medicines for free or at a savings to patients who qualify. To learn more, visit www.PfizerHelpfulAnswers.com, or call 1-866-706-2400.Send Us Your Feedback
We value your views on this Annual Review. Did it help you to better understand Pfizer? Was the information presented in a reader-friendly manner? Please send your comments to firstname.lastname@example.org.
You can find more information about Pfizer at Today at Pfizer.
All trademarks appearing in this Annual Review are owned by or licensed to Pfizer Inc or its affiliates.
Wyeth is now part of Pfizer. The merger of local Wyeth and Pfizer entities may be pending in various jurisdictions and integration is subject to completion of various local legal and regulatory obligations. Accordingly, some changes will not become effective outside of the U.S. and Puerto Rico until the relevant go-live date. All content in this message is subject to works council and/or union consultations and other legal requirements where appropriate.
This Annual Review is produced by Pfizer's Policy, External Affairs and Communications group.
Design: Ideas On Purpose, New York Principal Photography: Catherine Ledner, Victor John Penner, Neil Selkirk